newsfilter
← Latest News
PR Newswire·

LumiraDx Lab Analysis Confirms its COVID-19 Antigen Test Detects the Omicron Variant

LONDON, Jan. 14, 2022 /PRNewswire/ -- LumiraDx (NASDAQ:LMDX), a next-generation point of care diagnostics company, today announced that results from ongoing testing and monitoring of COVID-19 variants show its SARS-CoV-2 Antigen test detects the Omicron